PSIP1 and cancer: In concordance with these observations, several studies showed that LEDGF/p75 overexpression in cancer cells promotes resistance to drugs that induce oxidative DNA damage and lysosomal cell death [12–14,18,25], leading one group to refer to this protein as a “guardian of lysosomal stability in human cancer” [14].